Price movement over the last 24 hours
AKR Corporindo Tbk vs UBC Medical Indonesia Tbk. — how do they compare? AKR Corporindo Tbk trades at Rp1,320 (market cap 26T, 15.27M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: AKR Corporindo Tbk is far larger — about 46.7× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 15.27M). Which is the better fit depends on your goals.
| AKRA | LABS | |
|---|---|---|
Market Cap | 26T | 556.95B |
Volume | 15.27M | 60.83M |
Lot | 152.7K | 608.34K |
Turnover | 20.11B | 10.26B |
Average Price | 1,316.87 | 168.64 |
Value | 20.11B | 10.26B |
Indicative Equilibrium Price | 1,320 | 152 |
Indicative Equilibrium Volume | 4.56K | 4.52K |
Trailing returns across standard periods
Latest headlines on both assets
PT AKR Corporindo Tbk was established in Surabaya on November 28, 1977 based on the Notarial Deed No. 46 of Sastra Kosasih, S.H., which was amended by Notarial Deed No. 26 of the same notary dated April 12, 1978 . In 2004, the Company changed its name from PT Aneka Kimia Raya Tbk to PT AKR Corporindo Tbk. PT Aneka Kimia Raya is the largest chemical distributor in Indonesia. The Company is dominantly positioned within the industry, distributing more than 40 chemical products. The Company is foreign investment.
Read more on AKRA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →